MS patients are being ‘denied’ access to NHS Sativex Says Media Report
Cannabis Law Report
AUGUST 20, 2021
The MS Society has said that thousands of multiple sclerosis patients are being denied access to the approved drug Sativex, which helps improve spasm symptoms in sufferers. The charity found that out of 106 clinical commissioning groups in England, only 49 were routinely offering cannabis based treatment. Source: [link].
Let's personalize your content